Key result
Preconception bisoprolol and flecainide improve cardiac function and enable successful delivery in a symptomatic DMD carrier.
Why the study?
Female Duchenne muscular dystrophy carriers can manifest symptoms during pregnancy, which complicates diagnosis and genetic counseling before conception.
Case Report (n=1)
Preconceptional diagnosis and medical management of symptomatic Duchenne Muscular Dystrophy carriers can improve maternal cardiac function and lead to favorable perinatal outcomes.
May support preconception therapy in symptomatic DMD carriers; extends case-level evidence but leaves generalizability open.
Duchenne Muscular Dystrophy (DMD) is an X-linked recessive disorder. Female carriers can manifest symptoms during pregnancy, complicating diagnosis and genetic counseling before conception. This is the first report of a DMD symptomatic carrier who was managed continuously from preconception through pregnancy for symptoms recognized before conception. A 31-year-old primipara woman was incidentally noted to have premature ventricular contractions, heart failure, and elevated creatine kinase levels 2 years before pregnancy. Genetic testing confirmed that the patient was a symptomatic carrier of DMD. She had no family history of muscular or cardiac disease, suggesting a de novo variant. She received genetic counseling and planned amniocentesis during pregnancy as prenatal diagnosis. After treatment with bisoprolol and flecainide, her cardiac function improved, and natural conception was achieved. Amniocentesis performed at 16 weeks of gestation indicated a 46, XX karyotype, leading to the decision to continue the pregnancy. From week 16 to 21, the fetus exhibited bradycardia due to blocked premature atrial contraction, which later improved, although the atrioventricular interval was prolonged. The mother delivered vaginally without any complications, and the infant's atrioventricular interval normalized. Preconceptional diagnosis and treatment for DMD carrier status are crucial for shared decision-making and to achieve favorable perinatal outcomes.
No takes yet. Share an insight, caveat, or question.
Kinugawa et al. (2024) conducted a case report in Symptomatic carrier of Duchenne Muscular Dystrophy (n=1). Preconception care (bisoprolol, flecainide, and genetic counseling) was evaluated on Pregnancy outcome and maternal cardiac function. Preconception care with bisoprolol and flecainide in a 31-year-old symptomatic Duchenne Muscular Dystrophy carrier improved cardiac function and led to a successful vaginal delivery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: